Project Grant HT94252410945
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$1.4M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
The University of Alabama at Birmingham (UAB) has been awarded a $740,075 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "PADI4 as a Driver and Therapeutic Target for Uveal Melanoma Therapy". The award, which runs from September 1, 2024 to August 31, 2027, will support UAB's research into novel therapeutic approaches for treating uveal melanoma, an aggressive form of eye cancer. As a leading research...
The University of Alabama at Birmingham (UAB) was awarded a $907,805 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award beginning April 15, 2022 will support research entitled "Elevated Uracil Glycosylase Coupled to Reduced Base Excision Repair Promotes AA PCA Progression." Per the grant details, UAB will investigate how specific DNA repair mechanisms may promote the progression...
The University of Alabama at Birmingham will use a $148,500 Project Grant from the Defense Health Agency to support research titled "SMART-BASED REPAIR OF NF1 PRE-MRNA." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions. Specifically, the university will investigate medical solutions for the battlefield by exploring RNA-based therapies to...
The University of Alabama at Birmingham (UAB) received a $1,139,184.00 Project Grant award from the Defense Health Agency for the research project "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA". The award, which began on August 15, 2023 and is scheduled for completion on August 14, 2027, is funded through the Military Medical Research and Development program (CFDA 12.420). This grant supports UAB's biomedical research efforts to transform health care for Service...
The University of Alabama at Birmingham was awarded a $220,326 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on April 1, 2025, with a completion date of March 31, 2027, supports the development of novel, selective PARP protein degraders for prostate cancer treatment, utilizing PSMA uptake enhancement. This research aims to transform healthcare for military service members, veterans, and the broader...
The University of Alabama at Birmingham will receive $670,729 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on DNA damage as a predictive biomarker for immunotherapy response in ovarian cancer. The three-year project grant awarded in July 2021 will support research to investigate medical solutions for the battlefield by exploring DNA damage as a potential predictor of whether patients...
The University of Alabama at Birmingham will receive $742,500 through a three-year Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from August 1, 2022 to July 31, 2025 to uncover and target the molecular mechanisms of tumor-intrinsic immunotherapeutic resistance in melanoma. The Military Medical Research and Development program, identified by CFDA #12.420, supports basic, applied, and...
The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...